Interogo Long-Term Equity has issued call options to Asker’s Chair of the Board
In total, 291,970 options, each entitling the holder to acquire one share, have been acquired by Mikael Stöhr at a price corresponding to market value of the options on the transaction date, based on a valuation conducted by an independent valuation institute applying the Black & Scholes valuation model. The total market value of the options at the time of the transaction has been calculated at approximately MSEK 4. The options have a term of approximately five years and the exercise price amounts to SEK 94.90 per Asker share, corresponding to 120% of the closing price of the company’s shares on Nasdaq Stockholm on 2 June 2026. The option terms include a value cap per option of SEK 237.20. [1]
Interogo currently holds a total of 154,014,801 shares in Asker through Strukturfonden HC15 AB, corresponding to approximately 40 per cent of the total number of shares and votes in Asker.
Asker has not participated in the offer, which has been made by Interogo on its own initiative. The transaction does not entail any dilution for other shareholders in Asker, nor does it incur any costs for Asker.
For further information, please contact:
Emma Rheborg, Head of Communication Asker Healthcare Group
Phone: +46 73 313 62 17
E-mail: [email protected]
Asker Healthcare Group is a partner to caregivers and patients across Europe providing medical products and solutions. We build and acquire leading companies that together support the healthcare system to improve patient outcomes, reduce total cost of care and ensure a fair and sustainable value chain. We are a European healthcare group that combines the entrepreneurial drive of strong local companies, with the abilities and collected knowledge of a large group – driving progress in the healthcare sector. The group has more than 5 000 employees in 19 countries and revenues amounting to SEK 17 billion.
-------------------
[1] Each option entitles the holder to purchase one share in Asker, provided that the share price at the time the options are exercised does not exceed 300% of the closing price as set out above. If the share price exceeds 300%, the number of shares per option shall be adjusted downwards.